riluzole has been researched along with Spinal Muscular Atrophies of Childhood in 3 studies
Riluzole: A glutamate antagonist (RECEPTORS, GLUTAMATE) used as an anticonvulsant (ANTICONVULSANTS) and to prolong the survival of patients with AMYOTROPHIC LATERAL SCLEROSIS.
Spinal Muscular Atrophies of Childhood: A group of recessive inherited diseases that feature progressive muscular atrophy and hypotonia. They are classified as type I (Werdnig-Hoffman disease), type II (intermediate form), and type III (Kugelberg-Welander disease). Type I is fatal in infancy, type II has a late infantile onset and is associated with survival into the second or third decade. Type III has its onset in childhood, and is slowly progressive. (J Med Genet 1996 Apr:33(4):281-3)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bosboom, W | 1 |
| Vrancken, AF | 3 |
| van den Berg, LH | 3 |
| Wokke, J | 1 |
| Iannaccone, ST | 3 |
| Wadman, RI | 2 |
| Bosboom, WM | 2 |
| Wokke, JH | 2 |
| van der Pol, WL | 1 |
3 reviews available for riluzole and Spinal Muscular Atrophies of Childhood
| Article | Year |
|---|---|
Drug treatment for spinal muscular atrophy type I.
Topics: Child, Preschool; Humans; Infant; Neuroprotective Agents; Randomized Controlled Trials as Topic; Ril | 2009 |
Drug treatment for spinal muscular atrophy type I.
Topics: Child, Preschool; Humans; Infant; Neuroprotective Agents; Randomized Controlled Trials as Topic; Ril | 2011 |
Drug treatment for spinal muscular atrophy type I.
Topics: Child, Preschool; Disease Progression; Humans; Infant; Neuroprotective Agents; Randomized Controlled | 2012 |